| Literature DB >> 31804076 |
Nan Zheng1, Prasoona Karra2, Michael A VandenBerg3, Jin Hwan Kim1, Matthew J Webber3, William L Holland2, Danny Hung-Chieh Chou1.
Abstract
Insulin has been a life-saving drug for millions of people with diabetes. However, several challenges exist which limit therapeutic benefits and reduce patient convenience. One key challenge is the fibrillation propensity, which necessitates refrigeration for storage. To address this limitation, we chemically synthesized and evaluated a methylene thioacetal human insulin analogue (SCS-Ins). The synthesized SCS-Ins showed enhanced serum stability and aggregation resistance while retaining bioactivity compared with native insulin.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31804076 PMCID: PMC7217704 DOI: 10.1021/acs.jmedchem.9b01589
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446